Bluebird Bio

Why bluebird bio Inc Continued Its March Higher Again Today
Why bluebird bio Inc Continued Its March Higher Again Today
Motley Fool
Bluebird Bio
bb2121
CAR-T
Novartis
Kymriah
Gilead Sciences
Kite Pharma
Flag link:
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
Motley Fool
Bluebird Bio
Juno Therapeutics
Gilead Sciences
Kite Pharma
CAR-T
M&A
Flag link:
Is This Why bluebird bio Dipped 10.5% in July?
Is This Why bluebird bio Dipped 10.5% in July?
Motley Fool
Bluebird Bio
gene therapy
bb2121
Flag link:
bluebird bio Pauses During 2017 Data Blitz
bluebird bio Pauses During 2017 Data Blitz
Motley Fool
Bluebird Bio
gene therapy
earnings
ASH
Flag link:
How Novartis' FDA Win In Cancer Also Could Be A Boon For Its Rivals
How Novartis' FDA Win In Cancer Also Could Be A Boon For Its Rivals
Investors Business Daily
Novartis
CAR-T
CTL019
Kite Pharma
Bluebird Bio
Flag link:
Billions of Dollars on the Line for Celgene With These 3 Small Biotechs
Billions of Dollars on the Line for Celgene With These 3 Small Biotechs
Motley Fool
Celgene
Juno Therapeutics
Acceleron
Bluebird Bio
Flag link:
Can Celgene, Bluebird Keep Their Lead As Rivals Champ At The Bit?
Can Celgene, Bluebird Keep Their Lead As Rivals Champ At The Bit?
Investors Business Daily
Celgene
Bluebird Bio
Kite Pharma
Juno Therapeutics
CAR-T
immuno-oncology
bb2121
Flag link:
Bluebird Bio: Too Much Good News?
Bluebird Bio: Too Much Good News?
Barron's
Bluebird Bio
bb2121
Celgene
Flag link:
Bluebird Reports Early Results From Upgraded Gene Therapy
Bluebird Reports Early Results From Upgraded Gene Therapy
Xconomy
Bluebird Bio
LentiGlobin
gene therapy
clinical trials
beta-thalassemia
Flag link:
3 Top-Performing Biotech Stocks This Week
3 Top-Performing Biotech Stocks This Week
Motley Fool
biotech
Kite Pharma
KTE-C19
Bluebird Bio
CAR-T
Lexicon Pharmaceuticals
Flag link:
Bluebird has a promising new update on its BCMA CAR-T for multiple myeloma, but is it still the leader?
Bluebird has a promising new update on its BCMA CAR-T for multiple myeloma, but is it still the leader?
Endpoints
Bluebird Bio
BCMA
CAR-T
Multiple Myeloma
ASCO 2017
bb2121
Celgene
Flag link:
Top Presentations to Look for at ASCO
Top Presentations to Look for at ASCO
Yahoo/24-7 Wall St
ASCO 2017
Merck
AbbVie
Eli Lilly
Bluebird Bio
Epizyme
Juno Therapeutics
Kite
Merus
Flag link:
bluebird bio Updates, Investors Wait
bluebird bio Updates, Investors Wait
Motley Fool
Bluebird Bio
earnings
Flag link:
Biotechs Breaking Out On Drug Development News
Biotechs Breaking Out On Drug Development News
Forbes
Bluebird Bio
Esperion Therapeutics
Amicus Therapeutics
Kite Pharma
Flag link:
Four biotech stocks surging on optimism about drug trials, product launches
Four biotech stocks surging on optimism about drug trials, product launches
Marketwatch
clinical trials
Bluebird Bio
Amicus Therapeutics
Kite Pharma
NeuroDerm
Flag link:
Bluebird Bio 4Q Loss Below Street Estimates
Bluebird Bio 4Q Loss Below Street Estimates
Investopedia
Bluebird Bio
earnings
Flag link:
Why bluebird bio Stock Surged 20.7% Higher in January
Why bluebird bio Stock Surged 20.7% Higher in January
Motley Fool
Bluebird Bio
Lenti-D
Flag link:
Twittering And Other Thoughts About bluebird bio
Twittering And Other Thoughts About bluebird bio
Seeking Alpha
Bluebird Bio
Flag link:
Bluebird bio stock gains on impressive early cancer trial results
Bluebird bio stock gains on impressive early cancer trial results
Bizjournals.com
Bluebird Bio
clinical trials
bb2121
Multiple Myeloma
Flag link:
5 Biotech IPOs Lead The Way In 2016
5 Biotech IPOs Lead The Way In 2016
Seeking Alpha
biotech
IPOs
AveXis
Clearside Biomedical
Protagonist Therapeutics
Reata Pharmaceuticals
Bluebird Bio
Flag link: